T he focus in heart failure with preserved ejection fraction (HFpEF) has historically centered on the heart, and afflicted patients clearly display abnormalities in left ventricular (LV) function that play a dominant role in the pathophysi- Importantly, low DLCO was associated with markedly increased mortality in HFpEF, with a 3-year survival of only 37% compared with 88% in patients with relatively preserved DLCO (p < 0.001). Low DLCO remained an independent predictor of mortality in multivariable analysis (hazard ratio: 6.6; 95% confidence interval: 2.6 to 16.9). The authors conclude that low DLCO is a strong predictor of mortality in patients with HFpEF and PH and that lung diffusion should be considered in future studies to refine prognosis and better characterize patients (10).
T he focus in heart failure with preserved ejection fraction (HFpEF) has historically centered on the heart, and afflicted patients clearly display abnormalities in left ventricular (LV) function that play a dominant role in the pathophysiology (1) . Recent studies have identified important roles for structures outside of the heart, including the systemic vasculature, endothelium, kidneys, and skeletal muscle (1) (2) (3) (4) . Left heart disease also causes problems in the lungs in HFpEF. Pulmonary hypertension (PH) develops in a substantial number of patients with HFpEF, which may lead to right ventricular dysfunction and increased risk of death (5-7).
The lungs sit immediately upstream of the left heart, so they ultimately bear the brunt of hydrostatic insults related to LV diastolic dysfunction (8) . As LV filling pressures increase, the Starling forces governing fluid distribution favor translocation of water from the vascular space to the interstitium at the pulmonary capillary-alveolar interface (8, 9) . Acutely, this may lead to the sensation of dyspnea or even the development of frank pulmonary edema. Over time, 
